506 related articles for article (PubMed ID: 27847912)
1. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
Traish A
Investig Clin Urol; 2016 Nov; 57(6):384-400. PubMed ID: 27847912
[TBL] [Abstract][Full Text] [Related]
2. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
Traish AM
Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
[TBL] [Abstract][Full Text] [Related]
3. [Testosterone and the prostate].
Sperling H; Rossi R; Lümmen G; Rübben H
Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045
[TBL] [Abstract][Full Text] [Related]
4. [Testosterone substitution in patients with hypogonadism].
Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
[TBL] [Abstract][Full Text] [Related]
5. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner MM; Seftel AD
Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular benefits and risks of testosterone replacement therapy in older men with low testosterone.
Chrysant SG; Chrysant GS
Hosp Pract (1995); 2018 Apr; 46(2):47-55. PubMed ID: 29478348
[TBL] [Abstract][Full Text] [Related]
7. [Testosterone substitution with special regard to prostate cancer].
Beintker M; Behre H
Urologe A; 2008 Dec; 47(12):1588-91. PubMed ID: 18931991
[TBL] [Abstract][Full Text] [Related]
8. Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
Hassan J; Barkin J
Can J Urol; 2016 Feb; 23(Suppl 1):20-30. PubMed ID: 26924592
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
10. Testosterone deficiency.
Traish AM; Miner MM; Morgentaler A; Zitzmann M
Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
[TBL] [Abstract][Full Text] [Related]
11. Management of Hypogonadism in Cardiovascular Patients: What Are the Implications of Testosterone Therapy on Cardiovascular Morbidity?
Tanna MS; Schwartzbard A; Berger JS; Underberg J; Gianos E; Weintraub HS
Urol Clin North Am; 2016 May; 43(2):247-60. PubMed ID: 27132583
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
Rhoden EL; Morgentaler A
J Urol; 2003 Dec; 170(6 Pt 1):2348-51. PubMed ID: 14634413
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
Afiadata A; Ellsworth P
Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
[TBL] [Abstract][Full Text] [Related]
14. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).
Saad F
Adv Exp Med Biol; 2017; 1043():527-558. PubMed ID: 29224109
[TBL] [Abstract][Full Text] [Related]
15. Hypogonadism management and cardiovascular health.
Auerbach JM; Khera M
Postgrad Med; 2020 Dec; 132(sup4):35-41. PubMed ID: 32799602
[TBL] [Abstract][Full Text] [Related]
16. [Testosterone therapy].
Diemer T; Hauptmann A; Wagenlehner FM
Urologe A; 2016 Apr; 55(4):539-48; quiz 549-50. PubMed ID: 27067659
[TBL] [Abstract][Full Text] [Related]
17. [Testosterone replacement therapy for hypogonadism in men with prostate cancer].
Jensen CF; Fode M; Østergren P; Sønksen J
Ugeskr Laeger; 2017 Feb; 179(9):. PubMed ID: 28263152
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review.
Shabsigh R; Crawford ED; Nehra A; Slawin KM
Int J Impot Res; 2009; 21(1):9-23. PubMed ID: 18633357
[TBL] [Abstract][Full Text] [Related]
19. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
20. Testosterone administration in older men.
Matsumoto AM
Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
